Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations

NCT03570619 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Castration Resistant Prostate Cancer
Metastatic Cancer
Solid Tumor

Interventions

DRUG: Nivolumab
DRUG: Ipilimumab

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]
[object Object]